How GSK can detect and halt unproductive payments

Supply Chain

By SAS On Jul 18, 2024

In this eBook, we’ll look at how a smarter, more data-driven approach to payment integrity can help GSK gain faster and deeper visibility of its spend across R&D, manufacturing and distribution, with the ability to highlight potential anomalies in real time for investigation by human experts.

First Name (required)

Last Name (required)

Email (required)

Phone/Mobile Number (required)

Designation (required)

Company Name (required)

Company Address (required)

City (required)

Postal Code (required)

I would like to be contacted by SAS representative.
Yes, I would like to receive email updates about SAS products, services and events.
For full details of how we will treat your information please view our privacy policy: SAS Privacy Policy

This is co-hosted by Express Pharma and SAS

By submitting this form, you are confirming you are an adult 18 years or older and agree to Express Pharma contacting you with marketing-related emails or by telephone. You may unsubscribe from receiving such communications from Express Pharma at any time. Express Pharma web sites and communications are subject to our Privacy Notice and Terms of Use.